chr11-68936491-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002180.3(IGHMBP2):ā€‹c.2011A>Gā€‹(p.Thr671Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.295 in 1,613,488 control chromosomes in the GnomAD database, including 74,641 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.25 ( 5443 hom., cov: 33)
Exomes š‘“: 0.30 ( 69198 hom. )

Consequence

IGHMBP2
NM_002180.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -1.58
Variant links:
Genes affected
IGHMBP2 (HGNC:5542): (immunoglobulin mu DNA binding protein 2) This gene encodes a helicase superfamily member that binds a specific DNA sequence from the immunoglobulin mu chain switch region. Mutations in this gene lead to spinal muscle atrophy with respiratory distress type 1. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.5120378E-4).
BP6
Variant 11-68936491-A-G is Benign according to our data. Variant chr11-68936491-A-G is described in ClinVar as [Benign]. Clinvar id is 258566.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-68936491-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.439 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
IGHMBP2NM_002180.3 linkuse as main transcriptc.2011A>G p.Thr671Ala missense_variant 13/15 ENST00000255078.8 NP_002171.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
IGHMBP2ENST00000255078.8 linkuse as main transcriptc.2011A>G p.Thr671Ala missense_variant 13/151 NM_002180.3 ENSP00000255078 P1

Frequencies

GnomAD3 genomes
AF:
0.250
AC:
37938
AN:
151982
Hom.:
5448
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.129
Gnomad AMI
AF:
0.152
Gnomad AMR
AF:
0.181
Gnomad ASJ
AF:
0.377
Gnomad EAS
AF:
0.198
Gnomad SAS
AF:
0.455
Gnomad FIN
AF:
0.365
Gnomad MID
AF:
0.358
Gnomad NFE
AF:
0.305
Gnomad OTH
AF:
0.239
GnomAD3 exomes
AF:
0.291
AC:
72856
AN:
250432
Hom.:
12000
AF XY:
0.307
AC XY:
41619
AN XY:
135510
show subpopulations
Gnomad AFR exome
AF:
0.123
Gnomad AMR exome
AF:
0.129
Gnomad ASJ exome
AF:
0.368
Gnomad EAS exome
AF:
0.196
Gnomad SAS exome
AF:
0.456
Gnomad FIN exome
AF:
0.379
Gnomad NFE exome
AF:
0.311
Gnomad OTH exome
AF:
0.296
GnomAD4 exome
AF:
0.300
AC:
438739
AN:
1461388
Hom.:
69198
Cov.:
54
AF XY:
0.308
AC XY:
223655
AN XY:
727002
show subpopulations
Gnomad4 AFR exome
AF:
0.120
Gnomad4 AMR exome
AF:
0.132
Gnomad4 ASJ exome
AF:
0.364
Gnomad4 EAS exome
AF:
0.215
Gnomad4 SAS exome
AF:
0.456
Gnomad4 FIN exome
AF:
0.377
Gnomad4 NFE exome
AF:
0.298
Gnomad4 OTH exome
AF:
0.295
GnomAD4 genome
AF:
0.249
AC:
37933
AN:
152100
Hom.:
5443
Cov.:
33
AF XY:
0.254
AC XY:
18920
AN XY:
74356
show subpopulations
Gnomad4 AFR
AF:
0.128
Gnomad4 AMR
AF:
0.180
Gnomad4 ASJ
AF:
0.377
Gnomad4 EAS
AF:
0.198
Gnomad4 SAS
AF:
0.455
Gnomad4 FIN
AF:
0.365
Gnomad4 NFE
AF:
0.305
Gnomad4 OTH
AF:
0.237
Alfa
AF:
0.297
Hom.:
14634
Bravo
AF:
0.225
TwinsUK
AF:
0.293
AC:
1086
ALSPAC
AF:
0.300
AC:
1155
ESP6500AA
AF:
0.127
AC:
559
ESP6500EA
AF:
0.308
AC:
2645
ExAC
AF:
0.298
AC:
36138
Asia WGS
AF:
0.302
AC:
1047
AN:
3478
EpiCase
AF:
0.303
EpiControl
AF:
0.310

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 03, 2021- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015This variant is associated with the following publications: (PMID: 29083408, 32640185) -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Autosomal recessive distal spinal muscular atrophy 1 Benign:2
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Charcot-Marie-Tooth disease Benign:1
Benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Autosomal recessive distal spinal muscular atrophy 1;C4015349:Charcot-Marie-Tooth disease axonal type 2S Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Charcot-Marie-Tooth disease axonal type 2S Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
0.0060
DANN
Benign
0.24
DEOGEN2
Benign
0.080
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.020
N
LIST_S2
Benign
0.13
T
MetaRNN
Benign
0.00025
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.49
N
MutationTaster
Benign
1.0
P
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.27
N
REVEL
Benign
0.18
Sift
Benign
0.94
T
Sift4G
Benign
0.73
T
Polyphen
0.0
B
Vest4
0.0090
MPC
0.19
ClinPred
0.00067
T
GERP RS
-6.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.024
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs622082; hg19: chr11-68703959; COSMIC: COSV54820189; COSMIC: COSV54820189; API